Severin Schwan, CEO of Swiss pharma giant Roche, has warned that the demand for Covid-19 tests still outstrips supply, making more broad-based testing challenging.
This content was published on
2 minutes
Keystone-SDA/jdp
“It is very likely that vaccines will only be broadly available later next year so I expect the demand to outstrip supply for a number of months and even beyond then,” Schwan said in a briefing to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
Since the start of the pandemic, Roche has been a major developer of tests to detect and diagnose Covid-19. It has received Emergency Use Authorization from the US authorities for its PCR diagnostic as well as antibodies tests, while it has also developed a test to differentiate between flu and Covid-19 strains.
Schwan said it will be important even beyond the pandemic to use testing to distinguish between diseases showing similar symptoms, such as influenza.
Targeted vs mass testing
While some neighbouring countries such as Austria have pushed for more widespread testing, Switzerland has up to now encouraged testing only for people showing Covid-19 symptoms. A few days ago, Graubünden became the first canton to launch a pilot programme to conduct mass testing of residents as part of its measures to shore up the ski season.
Schwan acknowledged that testing more broadly offers an opportunity to open up the economy but said the quantities are simply not available. “It is important that testing is prioritised. First, we need to take care of symptomatic patients and healthcare workers. Only if volumes allow for broader testing, should we go in this direction,” he said during the briefing.
SWISS international airlines announced at the end of September that it would start testing passengers on certain flights with tests developed by Roche.
Although PCR tests remain the gold standard in Covid-19 testing, Schwan said that rapid antigen tests can be produced at much larger scale – which could open the door for broader coverage of the population.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
Swiss institute hosted informal talks between Russians, Ukrainians and Americans
This content was published on
The Geneva Center for Security Policy (GCSP) has hosted 10 meetings between Russian and Ukrainian interlocutors since the start of the war.
Automated driving on Swiss motorways is theoretically possible from March
This content was published on
It will be theoretically possible to hand over the steering wheel to technology but no such system has been submitted for official approval yet.
Heated atmosphere at Swiss rally against AfD politician Alice Weidel
This content was published on
Around 250 people demonstrated "against the right" and the German AfD politician Alice Weidel on Saturday afternoon in Einsiedeln.
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Roche poised to launch mass Covid testing
This content was published on
Swiss drug firm Roche says it is to launch a new Covid-19 antigen test before the end of the year, allowing faster, higher-volume testing.
This content was published on
Swiss firm Roche receives US Emergency Use Authorization for a test to quickly detect whether a patient has Covid-19 or one of two forms of flu.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.